World Health Organization (WHO)

Human medicines European public assessment report (EPAR): Leqembi, lecanemab, Date of authorisation: 15/04/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Atazanavir Krka, atazanavir, Date of authorisation: 25/03/2019, Revision: 3, Status: Authorised

Agenda - Workshop on the use of Bayesian statistics in clinical development

Human medicines European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), levodopa,carbidopa,entacapone, Date of authorisation: 11/11/2013, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Abrysvo, respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Tecartus, brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 12, Status: Authorised

Pharmacovigilance Risk Assessment Committee (PRAC): 2 - 5 June 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 June 2025 to 5 June 2025

Faecal microbiota transplantation EU-IN Horizon Scanning Report

Agenda of the PRAC meeting 2-5 June 2025